The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

Pharma is understandably risk-averse, and many companies remain in pilot mode, running small experiments that never scale.

Explore how sponsors can recalibrate efficiency efforts to avoid overconcentrating trials at familiar sites and instead ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

The new rules introduce a fast-track notification route, enabling quicker starts for lower-risk trials and maintaining safety ...

Innovations in clinical trial designs and tools have the potential to unlock a new era of research that is more convenient for patients, more reflective of real-world treatment conditions, and more ...